Angela Lamarca· @DrAngelaLamarca · X·· 16 小时前评分70
正文 · 原文
HARMONI-GI1 at the @myESMO #ESMO26 #Presidential of CisGem + #ivonescimab vs durvalumab in #firstline #BiliaryMalignancies
✅OS HR 0.75, mOS 12.1vs14.9
✅PFS HR 0.61, mPFS 6.8vs8.4
✅ORR 53.8vs32.5
🌐China only
BUT
😊This is a positive trial
🥳VEGF is back
#ESMOAmbassadors
58 浏览 · 1 赞 · 2 转发 · 0 回复
来源:Angela Lamarca · x.com
